Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    MyBucks

    MCap

    EUR1m

    Last close

    EUR0.06

    ▲ 0.05 (400.00%)

    MagForce

    MCap

    —

    Last close

    EUR0.02

    ▲ 0.01 (100.00%)

    OpGen

    MCap

    USD7m

    Last close

    USD0.17

    ▲ 0.04 (30.77%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

Executive interview – Heidelberg Pharma at EKF 2019

Executive interview – Heidelberg Pharma at EKF 2019

In this interview, Dr Jan Schmidt-Brand, CEO of Heidelberg Pharma, provides an overview of the company and what differentiates its ATAC products from other ADC or CAR-Ts on the market. He also shares the company’s key partnerships and pipeline overview, the upcoming catalysts investors should pay attention to, and how the company is funded.

< Previous
Next >

You may also be interested in these:

TMT

The MISSION Group - executive interview

Investment Companies

Vantage: Paul Sedgwick of Frank Investments gives his insight into running a balanced portfolio

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free